Lilly, Novo Nordisk near White House deals on obesity drug prices, Endpoints News reports
(Reuters) -Eli Lilly and Novo Nordisk plan to announce new drug pricing deals with the White House, including for their weight loss medicines, in return for Medicare coverage of their products, Endpoints News reported on Tuesday. Under the deal, the companies...
Reuters